Withdrawn study sought to measure drug transfer to nursing babies
NCT ID NCT06181630
Summary
This study aimed to measure how much ozanimod medication passes into breast milk when taken by nursing mothers. It planned to enroll women already using ozanimod who had recently given birth, to assess the drug's concentration in their milk and monitor their infants for any effects. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATING WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Las Vegas Clinical Research Unit
Las Vegas, Nevada, 89113-2228, United States
Conditions
Explore the condition pages connected to this study.